UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer

BMC cancer, 2020-04, Vol.20 (1), p.275-275, Article 275

2020

Volltextzugriff (PDF)

Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer

Cancers, 2021-09, Vol.13 (19), p.4734

2021

Volltextzugriff (PDF)

The role of Dickkopf-3 overexpression in esophageal adenocarcinoma

The Journal of thoracic and cardiovascular surgery, 2015-08, Vol.150 (2), p.377-385.e2

2015

Volltextzugriff (PDF)

Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery

BMC pulmonary medicine, 2021-03, Vol.21 (1), p.75-8, Article 75

2021

Volltextzugriff (PDF)

BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4 / BAP1 and the Proteasome Subunit rpn-9 / PSMD13

Cells (Basel, Switzerland), 2023-03, Vol.12 (6), p.929

2023

Volltextzugriff (PDF)

Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer

JCO precision oncology, 2021-11, Vol.5 (5), p.93-102

2021

Volltextzugriff (PDF)

Linkage of DNA Methylation Quantitative Trait Loci to Human Cancer Risk

Cell reports (Cambridge), 2014-04, Vol.7 (2), p.331-338

2014

Volltextzugriff (PDF)

Molecular Nodal Restaging Based on CEACAM5, FGFR2b and PTPN11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell Lung Cancer

Journal of investigative surgery, 2022-02, Vol.35 (2), p.315-324

2022

Volltextzugriff (PDF)

Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin

Disease models & mechanisms, 2018-06, Vol.11 (6)

2018

Volltextzugriff (PDF)

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2024-09, Vol.404 (10459), p.1240-1252

2024

Volltextzugriff (PDF)

Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): A phase II multicenter exploratory study—Final data of patients who underwent surgical assessment

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.8509-8509

2019

Volltextzugriff (PDF)

Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities

Clinical and translational medicine, 2023-09, Vol.13 (9), p.e1413-e1413

2023

Volltextzugriff (PDF)

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

Cancers, 2021-08, Vol.13 (16), p.4168

2021

Volltextzugriff (PDF)

Epigenetic Regulation of Vitamin D Metabolism in Human Lung Adenocarcinoma

Journal of thoracic oncology, 2014-04, Vol.9 (4), p.473-482

2014

Volltextzugriff (PDF)

Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer

PloS one, 2015-03, Vol.10 (3), p.e0119878

2015

Volltextzugriff (PDF)

An eHealth ecosystem for stepped and early psychosocial care in advanced lung cancer: Rationale and protocol for a randomized control trial

Internet interventions : the application of information technology in mental and behavioural health, 2023-04, Vol.32, p.100620-100620, Article 100620

2023

Volltextzugriff (PDF)

RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants

JTO clinical and research reports, 2024-02, Vol.5 (2), p.100624-100624, Article 100624

2024

Volltextzugriff (PDF)

Urinary Cytokines Reflect Renal Inflammation in Acute Tubulointerstitial Nephritis: A Multiplex Bead-Based Assay Assessment

Journal of clinical medicine, 2021-07, Vol.10 (13), p.2986

2021

Volltextzugriff (PDF)

Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas

Oncotarget, 2016-08, Vol.7 (34), p.54867-54882

2016

Volltextzugriff (PDF)

Exploiting metabolic vulnerabilities of Non small cell lung carcinoma

Seminars in cell & developmental biology, 2020-02, Vol.98, p.54-62

2020

Volltextzugriff (PDF)

Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors

Cancer Immunology, Immunotherapy, 2019-03, Vol.68 (3), p.341-352

2019

Volltextzugriff (PDF)

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

Nature medicine, 2022-08, Vol.28 (8), p.1640-1645

2022

Volltextzugriff (PDF)

Reply to E.J. Lehrer et al and J.B. De Vis et al

Journal of clinical oncology, 2024-03, Vol.42 (7), p.859-861

2024

Volltextzugriff (PDF)

Mutations in the Antioxidant KEAP1/NRF2 Pathway Define an Aggressive Subset of NSCLC Resistant to Conventional Treatments

Journal of thoracic oncology, 2019-11, Vol.14 (11), p.1881-1883

2019

Volltextzugriff (PDF)

26 – 50 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(207)

Publikationsform

Artikel
(235)
Buchkapitel
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(136)
Life Sciences & Biomedicine
(130)
Oncology
(99)
Humans
(87)
Lung Cancer
(54)
Female
(47)
Male
(46)
Aged
(41)
Lung Neoplasms - Genetics
(40)
Middle Aged
(40)
Lung Neoplasms - Drug Therapy
(35)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(34)
Lung Neoplasms - Pathology
(34)
Mutation
(33)
Respiratory System
(32)
Tumors
(31)
Carcinoma, Non-Small-Cell Lung - Genetics
(30)
Patients
(30)
Non-Small Cell Lung Carcinoma
(28)
Immunotherapy
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 7 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Clinical performance evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed paraffin-embedded tissue of non-small cell lung cancer

Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer

The role of Dickkopf-3 overexpression in esophageal adenocarcinoma

Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery

BAP1 Malignant Pleural Mesothelioma Mutations in Caenorhabditis elegans Reveal Synthetic Lethality between ubh-4 / BAP1 and the Proteasome Subunit rpn-9 / PSMD13

Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer

Linkage of DNA Methylation Quantitative Trait Loci to Human Cancer Risk

Molecular Nodal Restaging Based on CEACAM5, FGFR2b and PTPN11 Expression Adds No Relevant Clinical Information in Resected Non-Small Cell Lung Cancer

Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

Neoadjuvant chemo-immunotherapy for the treatment of stage IIIA resectable non-small-cell lung cancer (NSCLC): A phase II multicenter exploratory study—Final data of patients who underwent surgical assessment

Transcriptional profiling of molecular pathways allows for the definition of robust lung squamous cell carcinoma molecular subtypes with specific vulnerabilities

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer

Epigenetic Regulation of Vitamin D Metabolism in Human Lung Adenocarcinoma

Elevated levels of the complement activation product C4d in bronchial fluids for the diagnosis of lung cancer

An eHealth ecosystem for stepped and early psychosocial care in advanced lung cancer: Rationale and protocol for a randomized control trial

RELAY, Erlotinib Plus Ramucirumab in Untreated, EGFR-Mutated, Metastatic NSCLC: Outcomes by EGFR Exon 19 Deletion Variants

Urinary Cytokines Reflect Renal Inflammation in Acute Tubulointerstitial Nephritis: A Multiplex Bead-Based Assay Assessment

Genomic similarity between gastroesophageal junction and esophageal Barrett's adenocarcinomas

Exploiting metabolic vulnerabilities of Non small cell lung carcinoma

Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

Reply to E.J. Lehrer et al and J.B. De Vis et al

Mutations in the Antioxidant KEAP1/NRF2 Pathway Define an Aggressive Subset of NSCLC Resistant to Conventional Treatments

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial)

Suchergebnisse filtern